• SENSEX 74,459.53
    308.49 (+0.42%)
  • BANKNIFTY 54,686.95
    -222.70 (--0.41%)
  • Jio Platforms
    1,438.95 1,490.00(%)
  • NSE
    1,775.20 1,640.25(%)
  • Dalmia BharatLtd
    1,320.00 1,320.00(%)
  • Anand Rathi Wea.
    2,246.45 1,354.00(%)
  • Reliance Industries
    1,152.50 1,152.30(%)
  • Ather Energy
    1,782.05 1,782.05(%)
  • Laurus Labs
    2,392.00 2,392.00(%)
  • Sagility
    41.79 35.82(%)
  • UltraTech Cem.
    11,005.00 10,329.00(%)
  • Tonbo Imaging
    1,330.00 1,343.80(%)
  • Indian Hotels Co
    824.00 824.00(%)
  • Trent
    3,059.00 3,399.75(%)
  • HDFC Bank
    695.50 1,017.90(%)
  • ICICI AMC
    2,688.00 2,528.90(%)
  • Hexaware Tech.
    497.95 400.35(%)
  • Suzlon Energy
    33.21 33.21(%)
  • Godrej Consumer
    777.65 777.65(%)
  • Diamond Power
    350.00 406.80(%)
  • Equitas Sma. Fin
    47.26 47.26(%)
  • APL Apollo Tubes
    2,161.00 1,691.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

SMS Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 25807.0
  • ISIN : INE812G01025
511.35 26 (5.26%)
  • As on 31 Oct 2026 (EOD)

  • Today’s Low

    482.20

  • Today’s High

    525.00

  • Open

    499.70

  • Perv Close

    485.80

  • 52W Low

    270.10

  • 52W High

    525.00

Key Indicators

  • P/E(TTM)

    52.92

  • Mar.Cap (₹Cr.)

    4,788.90

  • Div & Yield %

    0.08

  • Book Value(₹)

    85.93

  • Debt-Equity Ratio

    5.26

  • AGM Date

    30-Oct-2026

  • EPS

    9.67

  • P/E Ratio

    52.92

Financials Ratios

  • Debt-Equity Ratio

    0.54

  • Mar.Cap (₹Cr.)

    4,788.90

  • RONW (%)

    9.87

  • ROCE (%)

    11.69

Score Board

  • Equity (₹ in Cr.)

    9.37

  • BV (₹)

    85.90

  • Sales( ₹ in Cr.)

    886.87

  • NP (in Cr.)

    87.61

  • NP Var(%)

    28.0

  • Div%

    40.0

  • CPS (₹)

    13.60

  • EPS (₹)

    9.40

  • Traded Value (₹ in Lakhs)

    4,792.64

  • 52 Week High

    525.00

  • 52 Week Low

    270.10

  • Price BSE

    512.0

  • Price NSE

    511.00

  • Market Capital( in Cr.)

    4,792.64

  • P/C Ratio

    37.60

  • P/E Ratio

    54.70

  • Price Vs.BV

    9.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 971.53 835.55 752.35 554.56 555.34 611.60
Excise Duty 84.66 52.80 43.08 32.51 35.47 48.43
Net Sales 886.87 782.75 709.27 522.05 519.87 563.17
Other Income 8.35 6.22 4.46 4.91 5.20 3.45
Stock Adjustments 22.84 64.81 1.00 -36.08 112.50 -26.73
Total Income 918.06 853.78 714.73 490.88 637.57 539.89
EXPENDITURE :            
Raw Materials 516.87 495.54 425.04 299.52 387.80 313.27
Power and Fuel Cost 62.92 56.76 47.12 35.97 32.58 23.31
Employee Cost 75.00 69.72 56.78 50.08 51.02 41.17
Other Manufacturing Expenses 28.06 29.85 26.52 17.86 22.63 16.19
Selling and Administration Expenses 52.96 53.04 35.68 25.28 21.12 19.02
Miscellaneous Expenses 2.72 2.69 2.14 2.51 2.46 2.34
Employee Benefit Expenses 75.00 69.72 56.78 50.08 51.02 41.17
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 738.53 707.59 593.28 431.23 517.61 415.31
Operating Profit 179.53 146.20 121.45 59.65 119.97 124.59
Interest 23.34 18.54 23.60 21.97 19.16 11.19
Gross Profit 156.19 127.66 97.85 37.68 100.81 113.40
Depreciation 39.92 34.34 31.52 32.13 32.15 22.28
Profit Before Tax 116.27 93.32 66.33 5.55 68.66 91.12
Current Tax 25.93 19.64 15.13 0.00 14.92 16.05
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 2.73 5.30 1.78 1.47 -14.30 14.11
Reported Net Profit 87.61 68.38 49.42 4.08 68.04 60.96
Extraordinary Items 0.00 0.03 0.03 -0.04 0.00 -0.01
Adjusted Net Profit 87.61 68.35 49.39 4.12 68.04 60.97
Adjustment below Net Profit 0.03 -0.51 -0.07 -0.21 0.04 -0.16
P & L Balance brought forward 413.52 359.04 322.22 320.88 265.35 214.55
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 13.55 13.39 12.54 2.54 12.54 10.00
P & L Balance carried down 487.61 413.52 359.04 322.22 320.88 265.35
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 40.00 40.00 40.00 30.00 30.00 30.00
Dividend Per Share(Rs) 0.40 0.40 0.40 0.30 0.30 0.30
Earnings Per Share-Unit Curr 9.35 7.71 5.84 0.48 8.04 7.20
Earnings Per Share(Adj)-Unit Curr 9.35 7.71 5.84 0.48 8.04 7.20
Book Value 85.93 74.13 64.02 58.49 58.33 50.59
Book Value(Adj)-Unit Curr 85.93 74.13 64.02 58.49 58.33 50.59

Shareholding Pattern

  • Promoter Group

    68.07%

  • Public Share Holding

    31.93%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 10,066,740 10.75 10,066,740 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 53,678,270 57.32 53,678,270 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 63,745,010 68.07 63,745,010 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,101,513 1.18 1,101,513 23
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,190 0.00 1,190 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 181,827 0.19 181,827 5
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,284,530 1.37 1,284,530 30
2] Non Institution
Bodies Corporate 1,735,850 1.85 1,735,750 168
Clearing Members 226 0.00 226 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,022,403 2.16 2,021,503 490
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,025,925 7.50 7,025,925 9
Individuals holding nominal share capital up to Rs. 1 lakh 17,188,096 18.35 16,969,255 34,191
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 967 0.00 967 2
Others 648,523 0.69 648,523 4
Sub Total 28,622,490 30.56 28,402,649 34,867
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 93,652,030 100.00 93,432,189 34,904

Company Background

SMS Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs

  • SMS Pharmaceuticals Ltd
  • BSE Code : 25807.0
  • ISIN : INE812G01025

  • Incorporation Year

    1987

  • Registered Office

    8th Floor Trendset Jayabheri
    Connect Kondapur Serilingampal, Hyderabad,
    Telangana-500084

  • Telephone

  • FAX

  • Chairman

    P Ramesh Babu

  • Managing Director

    P Ramesh Babu

  • Company Secretary

    Thirumalesh Tumma

  • Auditor

    Suryanarayana & Suresh

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Aarthi Consultants Pvt Ltd
    1-2-285 Domalguda,
    ,
    Mumbai - Hyderabad - 500 029

SMS Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
SMS Pharma. 511.75 895.22 971.53 52.92 12.95
Abbott India 25,593.30 7,217.19 6,929.05 33.68 43.78
Astrazeneca Phar 6,367.35 2,304.07 2,275.58 93.84 27.86
Glaxosmi. Pharma 2,483.55 3,932.76 3,790.20 39.67 58.17
Novartis India 1,693.85 393.10 354.33 42.77 15.94
Cipla 1,380.00 20,102.60 18,979.95 42.06 13.88
Bliss GVS Pharma 648.40 773.53 729.81 60.26 12.51
Amrutanjan Healt 496.85 520.13 502.55 26.61 24.16
Fermenta Biotec. 417.55 474.15 450.25 19.49 18.77
Guj. Themis Bio. 362.50 168.25 165.82 96.93 18.05
Ambalal Sarabhai 35.00 19.52 3.94 64.81 6.77